Soyoung Park

Soyoung Park is a seasoned professional in finance and investment, currently serving as a General Partner at 1004 Venture Partners, where the focus is on transformative innovations in healthy aging and longevity. In tandem, Soyoung holds roles as an Investor and Venture Partner at VU Venture Partners and as an Investor and Investment Due Diligence Director at HealthTech Capital, both entities dedicated to supporting innovative startups. Previous experience includes senior financial management positions at Pfizer and Global Blood Therapeutics, emphasizing the integration of drug development efforts and financial planning in the context of patient care, particularly for sickle cell disease. Soyoung's background is further enriched by consultancy roles across various companies and a robust educational foundation, including an MBA from Duke University and advanced accounting proficiency from Santa Clara University.